Cediranib combined with chemotherapy reduces tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts with different responsiveness to cisplatin.

Decio, Alessandra

Cediranib combined with chemotherapy reduces tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts with different responsiveness to cisplatin. [electronic resource] - Clinical & experimental metastasis Oct 2015 - 647-58 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1573-7276

10.1007/s10585-015-9734-1 doi


Angiogenesis Inhibitors--pharmacology
Animals
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Cisplatin--pharmacology
Female
Humans
Mice
Mice, Nude
Ovarian Neoplasms--pathology
Paclitaxel--pharmacology
Quinazolines--pharmacology
Xenograft Model Antitumor Assays